3.55 USD
▼-1.79-33.52%
盘后 6.20 0.00%
2026-09-16
市值
$1.91M
市盈率
—
EPS
-102.42
股息率
—
52 周区间
3.47 – 179.19
成交量
258.64K
Beta
-0.08
目标价
—
52W 低 3.4752W 高 179.19
价格走势
公司简介
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company’s product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; and ART12.11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and inso...